| Symbol |
Name |
|
AANAT
|
aralkylamine N-acetyltransferase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACO1
|
aconitase 1, soluble
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADCY2
|
adenylate cyclase 2 (brain)
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADD2
|
adducin 2 (beta)
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
AQP9
|
aquaporin 9
|
|
ASIC1
|
acid sensing (proton gated) ion channel 1
|
|
ATF1
|
activating transcription factor 1
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
C5AR1
|
complement component 5a receptor 1
|
|
CACNA1B
|
calcium channel, voltage-dependent, N type, alpha 1B subunit
|
|
CACNA1E
|
calcium channel, voltage-dependent, R type, alpha 1E subunit
|
|
CAD
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
|
|
CASR
|
calcium-sensing receptor
|
|
CD28
|
CD28 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD4
|
CD4 molecule
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CORO1B
|
coronin, actin binding protein, 1B
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CRYAB
|
crystallin, alpha B
|
|
DAZAP1
|
DAZ associated protein 1
|
|
DBI
|
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)
|
|
DGKD
|
diacylglycerol kinase, delta 130kDa
|
|
DNM1
|
dynamin 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
ESR1
|
estrogen receptor 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
FOXO3
|
forkhead box O3
|
|
FPR2
|
formyl peptide receptor 2
|
|
FXYD1
|
FXYD domain containing ion transport regulator 1
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GNAI2
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2
|
|
GNG12
|
guanine nucleotide binding protein (G protein), gamma 12
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GUCY2C
|
guanylate cyclase 2C
|
|
HABP4
|
hyaluronan binding protein 4
|
|
HDAC7
|
histone deacetylase 7
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
ILF3
|
interleukin enhancer binding factor 3, 90kDa
|
|
INSR
|
insulin receptor
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGB4
|
integrin, beta 4
|
|
JUN
|
jun proto-oncogene
|
|
KCNA1
|
potassium channel, voltage gated shaker related subfamily A, member 1
|
|
KCNAB2
|
potassium channel, voltage gated subfamily A regulatory beta subunit 2
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNJ12
|
potassium channel, inwardly rectifying subfamily J, member 12
|
|
KCNJ3
|
potassium channel, inwardly rectifying subfamily J, member 3
|
|
KCNJ4
|
potassium channel, inwardly rectifying subfamily J, member 4
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
LASP1
|
LIM and SH3 protein 1
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LTB4R
|
leukotriene B4 receptor
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAP1LC3B
|
microtubule-associated protein 1 light chain 3 beta
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK15
|
mitogen-activated protein kinase 15
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
|
MARK2
|
MAP/microtubule affinity-regulating kinase 2
|
|
MEP1B
|
meprin A, beta
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYL12B
|
myosin, light chain 12B, regulatory
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NCF2
|
neutrophil cytosolic factor 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
OPRD1
|
opioid receptor, delta 1
|
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited
|
|
PITPNC1
|
phosphatidylinositol transfer protein, cytoplasmic 1
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLCB3
|
phospholipase C, beta 3 (phosphatidylinositol-specific)
|
|
PLCD1
|
phospholipase C, delta 1
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PRDX6
|
peroxiredoxin 6
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCG
|
protein kinase C, gamma
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PXN
|
paxillin
|
|
RALB
|
v-ral simian leukemia viral oncogene homolog B
|
|
RBM17
|
RNA binding motif protein 17
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RGS5
|
regulator of G-protein signaling 5
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SH2B1
|
SH2B adaptor protein 1
|
|
SLC24A2
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2
|
|
SLC4A3
|
solute carrier family 4 (anion exchanger), member 3
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SNAP23
|
synaptosomal-associated protein, 23kDa
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SP1
|
Sp1 transcription factor
|
|
SPHK1
|
sphingosine kinase 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SSTR2
|
somatostatin receptor 2
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STK17B
|
serine/threonine kinase 17b
|
|
STMN1
|
stathmin 1
|
|
SYK
|
spleen tyrosine kinase
|
|
TBC1D4
|
TBC1 domain family, member 4
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TFRC
|
transferrin receptor
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VIM
|
vimentin
|
